A Video News Show for Health Professionals. New broadcasts monthly, with online video and transcripts. http://www.fda.gov/psn/ en-us Wed, 01 Jul 2009 04:00:00 GMT psnews@cdrh.fda.gov http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/psn/rsslogo.gif http://www.fda.gov/psn/ FDA will require that two topical testosterone gel products carry a boxed warning stating that children could be inadvertently exposed to testosterone if they contact the gel on the skin of another person, and listing specific recommendations to prev... Wed, 01 Jul 2009 04:00:00 GMT http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/psn/transcript-rss.cfm?show=88#1 http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/psn/transcript-rss.cfm?show=88#1 Disetronic Medical Systems is notifying healthcare professionals and patients about a possible defect with the some of the company's ACCU-CHEK Spirit insulin pumps. The defect can cause the "up" and "down" buttons on these pumps to stop working, ... Wed, 01 Jul 2009 04:00:00 GMT http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/psn/transcript-rss.cfm?show=88#2 http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/psn/transcript-rss.cfm?show=88#2 New information has been added to the labeling of the chemotherapy drug Tarceva (erlotinib). The revised labeling now warns about three kinds of serious adverse events: ? Gastrointestinal perforation, which may be fatal. This risk is increased i... Wed, 01 Jul 2009 04:00:00 GMT http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/psn/transcript-rss.cfm?show=88#3 http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/psn/transcript-rss.cfm?show=88#3 FDA is updating earlier recommendations about the interaction between the antibiotic ceftriaxone and intravenous products that contain calcium. In certain circumstances, this interaction can cause dangerous precipitates to form. Ceftriaxone is sold... Wed, 01 Jul 2009 04:00:00 GMT http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/psn/transcript-rss.cfm?show=88#4 http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/psn/transcript-rss.cfm?show=88#4 FDA wants healthcare professionals to know about two serious safety problems that have occurred in patients who use denture cleansers. The first is the risk of allergic reactions to these products. These reactions can arise soon after the initial u... Wed, 01 Jul 2009 04:00:00 GMT http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/psn/transcript-rss.cfm?show=88#5 http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/psn/transcript-rss.cfm?show=88#5 A recent FDA article in the journal Nursing 2009 warns about the possibility of burns from infant heel warmers. These devices are disposable heat packs used during neonatal care to increase circulation in the infant's heel. Activating the pack prod... Wed, 01 Jul 2009 04:00:00 GMT http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/psn/transcript-rss.cfm?show=88#6 http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/psn/transcript-rss.cfm?show=88#6 A recent FDA article describes medication errors that occurred with patients using Lamictal starter kits. Lamictal (lamotrigine) is used to treat epilepsy and bipolar disorder. The starter kits give patients the recommended initial dose and dose... Wed, 01 Jul 2009 04:00:00 GMT http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/psn/transcript-rss.cfm?show=88#7 http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/psn/transcript-rss.cfm?show=88#7 FDA and the Institute for Safe Medication Practices (ISMP) recently reported on several cases where people swallowed Benadryl Itch Stopping Gel, an OTC product that's supposed to be used topically. This has led to serious adverse reactions requiring... Wed, 01 Jul 2009 04:00:00 GMT http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/psn/transcript-rss.cfm?show=88#8 http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/psn/transcript-rss.cfm?show=88#8